0001652935 1 2026-07-31 2026-07-31 0001652935 2 2026-07-31 2026-07-31 0001652935 3 2026-07-31 2026-07-31 0001652935 2026-07-31 2026-07-31 iso4217:USD pure S-1 EX-FILING FEES 0001652935 N/A N/A S-1 Actuate Therapeutics, Inc. false Equity Common stock true 34500000.00 0.000087 3001.50 false Equity Warrants to be issued to the underwriter true 0.00 0.000087 0.00 false Equity Common stock underlying warrants to be issued to the underwriter true 1509375.00 0.000087 131.32 36009375.00 3132.82 0.00 3132.82 In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover an indeterminate number of additional shares of Common Stock to be offered or issued from stock splits, stock dividends or similar transactions. The proposed maximum aggregate offering price has been estimated solely to calculate the registration fee in accordance with Rule 457(o) under the Securities Act. No registration fee required pursuant to Rule 457(g). We have agreed to issue to the underwriter warrants to purchase shares of common stock representing up to 3.5% of the common stock issued in the offering. The underwriter’s warrants are exercisable at a per share exercise price equal to 125% of the public offering price per share of the common stock offered hereby.